Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients.
Open medicine (Warsaw, Poland) 2025 Lang Wang, Baoxin Ma, Jianping Zhang 1 citation
This study investigates the effects of subclinical doses of esketamine on serum NLRP3 levels and early cognitive dysfunction in elderly ischemic stroke patients after neurointerventional procedures under general anesthesia. A prospective cohort study included 120 elderly ischemic stroke patients undergoing general anesthesia from January 2022 to September 2023. The esketamine group received...
DOI: 10.1515/med-2025-1193 (opens in new tab)
Full text (opens in new tab)
Esketamine
Neuroprotection
Mmse
Nlrp3
+6